‘Smart patch’ could help detect Alzheimer’s disease
Scientists have developed a new "smart patch" that can detect biomarkers of neurodegenerative diseases (such as Parkinson's and Alzheimer's).
Alzheimer’s: blood biomarker may help identify the disease ten years before symptoms start
Though Alzheimer’s disease affects more than 55 million people worldwide, there’s still no cure for the condition – and treatment options are limited.
While recent...
Picking your nose may increase risk of Alzheimer’s disease, study finds
The olfactory nerve in the nose is directly exposed to air and offers a short pathway to the brain, one which bypasses the blood-brain barrier.
It’s...
Major Alzheimer’s risk factors harm men more than women
In a study from the University of Alberta, scientists found that important risk factors in Alzheimer's disease affect men and women very differently.
They used...
Scientists develop new sensor to detect Alzheimer’s early
In a study from SFU Nanodevice Fabrication Group, scientists developed a new biosensor that can be used to screen for Alzheimer's disease and other...
This diabetes drug can help protect against Alzheimer’s disease
In a study from Karolinska Institutet, scientists found mechanisms associated with a particular diabetes drug can also help to protect against Alzheimer's disease.
The findings...
Hormone therapy may prevent Alzheimer’s disease in older women
In a study from the University of East Anglia and elsewhere, scientists found that hormone Replacement Therapy (HRT) could help prevent Alzheimer's Dementia among...
1 in 2 older Americans with Alzheimer’s disease falls, study finds
With falls causing millions of injuries in older adults each year, it is an increasingly important public health concern.
In a study from Drexel University and elsewhere,...
Managing emotions better may prevent brain disease in older people
Negative emotions, anxiety, and depression are thought to promote the onset of neurodegenerative diseases and dementia.
But what is their impact on the brain and...
What the FDA’s accelerated approval of a new Alzheimer’s drug could mean for those...
The U.S. Food and Drug Administration approved the medication lecanemab, sold under the brand name Leqembi, on Jan. 6, 2023, through an “accelerated approval...